NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $15,000 | -6.2% | 200 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $16,000 | -5.9% | 200 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | -16.7% |
Q2 2017 | $17,000 | +13.3% | 200 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $15,000 | 0.0% | 200 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $15,000 | -77.6% | 200 | -78.4% | 0.01% | -78.3% |
Q1 2016 | $67,000 | -40.2% | 925 | -28.8% | 0.02% | -42.5% |
Q4 2015 | $112,000 | -5.9% | 1,300 | 0.0% | 0.04% | -9.1% |
Q3 2015 | $119,000 | -7.0% | 1,300 | 0.0% | 0.04% | +2.3% |
Q2 2015 | $128,000 | 0.0% | 1,300 | 0.0% | 0.04% | -2.3% |
Q1 2015 | $128,000 | -32.6% | 1,300 | -36.6% | 0.04% | -31.2% |
Q4 2014 | $190,000 | +2.7% | 2,050 | 0.0% | 0.06% | +4.9% |
Q2 2014 | $185,000 | -4.1% | 2,050 | -9.9% | 0.06% | -4.7% |
Q1 2014 | $193,000 | -27.7% | 2,275 | -31.6% | 0.06% | -38.5% |
Q4 2013 | $267,000 | -1.8% | 3,327 | -6.2% | 0.10% | -7.1% |
Q3 2013 | $272,000 | -58.3% | 3,547 | -61.5% | 0.11% | -61.4% |
Q2 2013 | $652,000 | – | 9,213 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |